Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Morag A Taylor a University Department
of Medicine, Glasgow Royal Infirmary, Glasgow G31 2ER, b Department of
Psychological Medicine, University of Sydney, New South Wales 2006, Australia, c University Department of Immunology, Western Infirmary,
Glasgow G11 6NT, d Department of Statistics, University of Glasgow,
Glasgow G12 8QQ
Correspondence to: D Reilly, Academic
Departments, Glasgow Homoeopathic Hospital, Glasgow G12 0XQ davidreilly1{at}compuserve.com
Objective:
To test the hypothesis that homoeopathy is a placebo by examining its effect in patients with allergic rhinitis and so contest the evidence from three previous trials in this series.
Design:
Randomised, double blind, placebo controlled, parallel group, multicentre study.
Setting:
Four general practices and a hospital
ear, nose, and throat outpatient department.
Participants:
51 patients with perennial allergic rhinitis.
Intervention:
Random assignment to an oral 30c
homoeopathic preparation of principal inhalant allergen or to placebo.
Main outcome measures:
Changes from baseline in nasal
inspiratory peak flow and symptom visual analogue scale score over
third and fourth weeks after randomisation.
Results:
Fifty patients completed the study. The
homoeopathy group had a significant objective improvement in nasal
airflow compared with the placebo group (mean difference 19.8 l/min,
95% confidence interval 10.4 to 29.1, P=0.0001). Both groups reported improvement in symptoms, with patients taking homoeopathy reporting more improvement in all but one of the centres, which had more patients
with aggravations. On average no significant difference between the
groups was seen on visual analogue scale scores. Initial aggravations
of rhinitis symptoms were more common with homoeopathy than placebo (7 (30%) v 2 (7%), P=0.04). Addition of these results to
those of three previous trials (n=253) showed a mean symptom reduction
on visual analogue scores of 28% (10.9 mm) for homoeopathy compared
with 3% (1.1 mm) for placebo (95% confidence interval 4.2 to 15.4, P=0.0007).
Conclusion:
The objective results reinforce earlier
evidence that homoeopathic dilutions differ from placebo.
Read all Rapid Responses
UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care